FAST NEWS: BeiGene Loss Narrows on Brisk Sales for Core Products
The latest: Cancer drug maker BeiGene Ltd. (BGNE.US; 6160.HK; 668235.SH) announced Monday its revenue rose 20.4% last year to $1.42 billion, thanks to big increases from its two core products,…
6160.HK
FAST NEWS: Zai Lab’s Loss Narrows as Core Products Post Strong Growth
The latest: Biotech company Zai Lab Ltd. (9688.HK; ZLAB.US) on Wednesday reported a $137.9 million net loss in the second quarter, 15.4% narrower than its $163 million loss a year earlier. Looking…
FAST NEWS: Ascletis Pharma’s Cancer Drug Eyes U.S. with New Drug Application
The latest: Ascletis Pharma Inc. (1672.HK) announced it has filed an Investigational New Drug (IND) application in the U.S. for its self-house developed oral PD-L1 small molecule inhibitor, ASC61, for the…
